From Bench to Bedside, and back again!
Our UCSF MS Center is an internationally recognized leader in multiple sclerosis clinical research. Our seamless collaboration between clinical and basic scientists allows us to pursue innovative avenues "from the bench to the bedside", and back again. Under the direction of Dr. Bruce Cree and his colleagues, the Research Center conducts clinical trials involving the use of experimental treatments, as well as observational studies that help better understand the natural history of the disease. We are trying to understand what role genes, the environment and the immune system have in multiple sclerosis and other neuroimmunological diseases. We focus primarily on MS, but also, we also study other diseases such as neuromyelitis optica (NMO), optic neuritis, transverse myelitis, encephalitis and sarcoidosis.
Recent Advances• New immune approaches, such as targeting B cells in MS treatment
• The launch of the first clinical trial aimed at remyelination, the ReBUILD study
• Uncovering the role of gene-environment interactions in MS risk
• Embracing the latest technologies, to create innovative tools, such as the MS BioScreen
Questions about research?
) at (415)502-7216